🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, multi-center, single arm study assessing the efficac...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2021-01-21
Trial ID
NCT04982549
Treatments Being Tested
Cisplatin and Etoposide is the standard of care in NEC originating from the...
Status
Unknown
Location
S.C. Oncologia - Policlinico
Start Date
2015-05
Trial ID
NCT02687958
Treatments Being Tested
This Phase 3 study was a randomized, double-blind, placebo-controlled, mult...
Status
Completed
Location
The Second Hospital of Anhui Medical University
Start Date
2019-07-22
Trial ID
NCT04005716
Treatments Being Tested
Etoposide-cisplatin/ -carboplatin in combination with PD-L1 inhibitor for 4...
Status
Completed
Location
Hunan cancer hospital
Start Date
2020-06-01
Trial ID
NCT04636762
Treatments Being Tested
This is a phase II/III randomized controlled trial to evaluate efficacy of ...
Status
Unknown
Location
N.N. Blokhin Cancer Research Center
Start Date
2019-09-01
Trial ID
NCT04055038
Treatments Being Tested
The trial investigates a stage-adapted (stage IIA or IIB) de-escalation of ...
Status
Active Not Recruiting
Location
Rotkreuzklinikum München
Start Date
2019-07-29
Trial ID
NCT03937843
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Northeast Alabama Regional Medical Center
Start Date
1994-09
Trial ID
NCT00002596
This is a single arm, Phase II trial involving the use of atezolizumab plus...
Status
Recruiting
Location
Johns Hopkins University: Sibley Memorial Hospital
Start Date
2022-06-27
Trial ID
NCT05312671
Treatments Being Tested
Researchers are looking for new ways to treat Limited-Stage Small Cell Lung...
Status
Active Not Recruiting
Location
Ironwood Cancer & Research Centers ( Site 0007)
Start Date
2020-12-08
Trial ID
NCT04624204
The purpose of the study is to determine whether the addition of Ipilimumab...
Status
Completed
Location
Genesis Cancer Center
Start Date
2011-12-13
Trial ID
NCT01450761
Treatments Being Tested